Estrogen receptor alpha (ERα) mRNA copy numbers in immunohistochemically ERα-positive-, and negative breast cancer tissues

BACKGROUND: The presence of ERα is the basis for treating breast cancer patients with targeted molecular therapies that block estrogen stimulation of breast cancer cell division. To select patients for the above therapies, currently, the ERα presence in breast cancer tissues is determined in clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Poola, Indira, Yue, Qingqi
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851709/
https://www.ncbi.nlm.nih.gov/pubmed/17391528
http://dx.doi.org/10.1186/1471-2407-7-56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851709/
https://www.ncbi.nlm.nih.gov/pubmed/17391528
http://dx.doi.org/10.1186/1471-2407-7-56

Ejemplares similares